NICARDIPINE - APPLICATIONS IN ANESTHESIA PRACTICE

被引：23

作者：

TOBIAS, JD

机构：

[1] Division of Pediatric Anesthesiology/Critical Care Medicine, Department of Pediatrics, Vanderbilt University, Nashville, TN

来源：

JOURNAL OF CLINICAL ANESTHESIA | 1995年 / 7卷 / 06期

关键词：

CALCIUM CHANNEL BLOCKERS; NICARDIPINE;

D O I：

10.1016/0952-8180(95)00093-W

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Nicardipine is the first intravenously administered dihydropyridine calcium channel blocker. Its primary physiologic actions include vasodilatation with limited effects on the inotropic and dromotropic function of the myocardium. Nicardipine has been used to control blood pressure intraoperatively in response to tracheal intubation and in the postoperative period. Various patient populations have been included such as major vascular and cardiovascular surgery. It has also been used as an agent for controlled hypotension. Preliminary experience suggests that nicardipine provides safe and effective control of perioperative blood pressure. The basic pharmacology and physiology of the most recently released calcium channel antagonist, nicardipine, is reviewed, and its applications in clinical anesthesia and interaction with other anesthetic drugs are discussed.

引用

页码：525 / 533

页数：9

共 56 条

[1]

Durand, Lehot, Foex, Calcium-channel blockers and anaesthesia, Can J Anaesth, 38, pp. 75-89, (1991)

[2]

Braunwald, Mechanism of action of calcium-channel blocking agents, N Engl J Med, 307, pp. 1618-1627, (1982)

[3]

Zipes, Fischer, Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog, Circ Res, 34, pp. 184-192, (1974)

[4]

Cranefield, Wit, Hoffman, Conduction of the cardiac impulse. 3. Characteristics of very slow conduction, J Gen Physiol, 59, pp. 227-246, (1972)

[5]

Graham, Dow, Freedman, Mroszczak, Ling, Pharmacokinetics of nicardipine following oral and intravenous administration in man, Postgrad Med J, 60, 4, pp. 7-10, (1984)

[6]

Lambert, Hill, Nichols, Feldman, Pepine, Coronary and systemic hemodynamic effects of nicardipine, Am J Cardiol, 55, pp. 652-656, (1985)

[7]

Frishman, New therapeutic modalities in hypertension: focus on a new calcium antagonist—nicardipine, J Clin Pharmacol, 29, pp. 481-487, (1989)

[8]

Clarke, Eglen, Patmore, Whiting, Cardioselective alcium channel entry blocking properties of nicardipine, nifedipine, and PY-108068 on cardiac and vascular smooth muscle, Br J Pharmacol, 79, pp. 333P-337P, (1983)

[9]

Rousseau, Etienne, Van Mechelen, Veriter, Pouleur, Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease, J Cardiovasc Pharmacol, 6, pp. 833-839, (1984)

[10]

Rogers, Hysing, Merin, Taylor, Hartley, Chelly, Cardiovascular effects of and interaction between calcium blocking drugs and anesthetics in chronically instrumented dogs. II. Verapamil, enflurane, and isoflurane, Anesthesiology, 64, pp. 568-575, (1986)

← 1 2 3 4 5 6 →